Bioinformatics

AssureRx: advanced genomics tools inform patient response to psychotropic therapy

By Brad Webb / September 17, 2012 / 0 Comments

Bloomberg reporter Ryan Flinn recently wrote an article on Brain Scans Seek Best Drug Match for Depression Patients. The article summarizes some of the technologies that are being used by clinicians to assist in diagnosis and treatment of depression, and focused on technologies provided by two companies. The first company profiled uses a technology that matches […]

Read More

Genetic testing to choose the right antidepressant – AssureRx Health in the news

By Claremont Creek Alerts / June 23, 2012 / 0 Comments

Claremont Creek Ventures portfolio company AssureRx Health continues to receive good press. Below are some excerpts from a recent FoxNews article published June 19, 2012. Read the full article at FoxNews.com Genetic testing to choose the right antidepressant By Dr. Keith Ablow. Psychiatrists often try two or more medications in a patient suffering with major depression […]

Read More

Claremont Creek Ventures’ portfolio company AssureRX updates its psychiatric drugs screening test

By Claremont Creek Alerts / January 18, 2012 / 0 Comments

January 18, 2012  source: MedCity News   Personalized medicine company AssureRx Health has released the next-generation version of its genetic screening test for psychiatric drugs. The Cincinnati-area company’s GeneSightRx test, which helps doctors pick the right psychiatric drugs for patients based on their genes, was launched in 2009. The test uses a cheek swab, mathematical […]

Read More

Claremont Creek Ventures’ portfolio company Gene Security Network in race for prenatal test

By Claremont Creek Alerts / December 15, 2011 / 0 Comments

September 9, 2011  source: originally published in the San Francisco Business Times Gene Security Network’s race to develop safer, more accurate prenatal test is all business for Matt Rabinowitz — and it’s personal. A relative of Rabinowitz, Gene Security Network’s CEO, took a blood test for the likelihood of Down’s syndrome in her unborn baby and […]

Read More
Gene Security Network

Why Dear Abby loves this company (and you should, too)

By John Steuart / September 12, 2011 / 0 Comments

Claremont Creek Ventures portfolio company Gene Security Network (GSN) achieved a technical breakthrough that even Dear Abby can crow about. Never before, have scientists and clinicians been about to measure fetal DNA in a pregnant woman’s blood with enough accuracy to determine paternity or relevant information about the baby in utero — until now. If […]

Read More
AssureRX

Claremont Creek Ventures portfolio company AssureRx Health expands senior management team

By Brad Webb / September 12, 2011 / 0 Comments

It is always great to brag and cheer about one of our portfolio companies. Working with portfolio companies to help them succeed is one of a VC’s key jobs, and helping build an executive team is an area where a VC can help a lot. We are pleased to announce that AssureRx Health has just […]

Read More

Meet our team

Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.

Nat_Boldhaber7718 -1200px

NAT GOLDHABER

Nat Goldhaber is a co-founder of Claremont Creek Ventures. 

Brad_Webb8124 1200px crop

BRAD WEBB

Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.

Randy_Hawks7690 -1200px

RANDY HAWKS

Randy Hawks is a co-founder of Claremont Creek Ventures.

Post Categories

Archives